Taylor & Francis Group

SHERPA: Unknown

People

  1. Geyer
    Geyer
  2. Park
    Park
  3. Derkach
    Derkach
  4. Abdel-Wahab
    Abdel-Wahab
  5. Daley
    Daley
  6. Daniyan
    Daniyan
  7. Goldberg
    Goldberg
  8. Jee
    Jee
  9. Kabel
    Kabel
  10. Lavery
    Lavery

Groups

  1. Adult Leukemia (8)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Biostatistics Service (2)
  6. Epidemiology and Biostatistics (2)
  7. GSK Faculty (2)
  8. Population Sciences Research Program (2)
  9. Survivorship Research (2)
  10. Advanced Practice Providers (1)
Search Within
  1. "Mark Geyer"
Formats
  1. Journal Article (4)
  2. Correspondence (1)
  3. Meeting Abstract (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Adult Leukemia (8)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Biostatistics Service (2)
  6. Epidemiology and Biostatistics (2)

More Groups

People
  1. Mark Geyer (8)
  2. Martin Tallman (5)
  3. Jae Park (4)
  4. Andriy Derkach (2)
  5. Anthony Mato (2)
  6. Lindsey Roeker (2)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (2)
Publications
  1. Leukemia and Lymphoma (7)
  2. Expert Review of Hematology (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Research Letter

    Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Journal Article

    Stahl, M.; Narendra, V.; Jee, J.; Derkach, A.; Maloy, M.; Geyer, M. B.; Mato, A. R.; Roeker, L. E.; Tallman, M. S.; Shah, G. L.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia
    Journal Article

    Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia
    Correspondence

    Gaulin, C.; Chan, A.; Derkach, A.; Park, J. H.; Mantha, S.; Geyer, M. B.; Tallman, M. S.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Phase I/II triple therapy study of umbralisib and ublituximab ("U2") combined with checkpoint inhibition in patients with rel/ref CLL and Richter's transformation
    Meeting Abstract

    Mato, A.; Svoboda, J.; Luning-Prak, E.; Schuster, S.; Tsao, P.; Dorsey, C.; Sarmasti, L.; Becker, P.; Brander, D.; Geyer, M.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • BRAF in the cross-hairs
    Review

    Geyer, M. B.; Abdel-Wahab, O.; Tallman, M. S.
    Expert Review of Hematology (2019)

    Fulltext@MSK | Save
  • Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells
    Journal Article

    Geyer, M. B.; Manjunath, S. H.; Evans, A. G.; Park, J. H.; Davila, M. L.; Cutler, C. S.; Wang, X.; Wang, Y.; Senechal, B.; Rivière, I.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Digging deeper in relapsed acute lymphoblastic leukemia: Impact of MRD status on outcome in second remission
    Journal Article

    Geyer, M. B.; Tallman, M. S.
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save